These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Price type key:
Federal Supply Schedule (FSS): generally available to all Federal Govt agencies /
'BIG4' prices: VA, DoD, Public Health & Coast Guard only /
National Contracts (NC): Available to specific agencies
71800-0031 Market Analysis and Financial Projection
The drug associated with NDC 71800-0031, identified as Lubricant Eye Drop (containing Propylene Glycol 0.6 g/100ml), is part of the expanding global eye drops and lubricants market. Below is a detailed analysis of its market positioning and price projections:
Market Analysis
Industry Growth Trends
Market Size and Projections:
The global eye drops and lubricants market was valued at $21.3 billion in 2024, with projections to reach $31.5 billion by 2033, growing at a CAGR of 4.21%[19][23][24].
The OTC dry eye drops segment alone is expected to grow from $3.49 billion (2024) to $3.79 billion (2025) at an 8.6% CAGR[25].
Key Drivers:
Rising prevalence of dry eye syndrome (affecting ~95% of post-laser surgery patients)[21].
Increased screen time, aging populations, and comorbidities like diabetes[19][20].
Demand for prescription and OTC solutions for redness, allergies, and post-surgical care[23].
Competitive Landscape:
Dominated by major players like Novartis (Alcon), Johnson & Johnson, and Bausch & Lomb[19][23].
Innovida Pharmaceutique (NDC 71800-0031’s manufacturer) is a smaller player, suggesting niche competition[13][15].
Price Projections
Factors Influencing Pricing
Inflation and Production Costs:
3.81% drug price inflation projected for 2025 may lead to moderate annual price increases[3][22].
Supply chain optimizations and regional manufacturing hubs could offset costs[3].
Regulatory and Policy Changes:
Potential shifts in U.S. healthcare policy under new administration could impact reimbursement structures[3].
Market Competition:
Competitive pressure from established brands may limit aggressive pricing[19][23].
Opportunities and Challenges
Opportunities
Challenges
Expanding into emerging markets
Reimbursement hurdles for Rx products
Partnerships with telehealth platforms
Competition from generics/alternatives
Digital health integration for adherence
Regulatory scrutiny on pricing
Strategic Recommendations
For Innovida Pharmaceutique:
Explore value-based pricing models to justify premium positioning.
Invest in real-world evidence to demonstrate efficacy in chronic dry eye management.
For Healthcare Providers:
Advocate for insurance coverage to improve patient access.
For Payers:
Develop tiered reimbursement plans to balance cost and therapeutic value.
Key Takeaways
NDC 71800-0031 operates in a high-growth market driven by demographic and lifestyle trends.
Prices are likely to rise ~3–4% annually, aligning with broader pharmaceutical inflation[3][22].
Strategic differentiation through targeted marketing and digital integration could enhance market share.
"The integration of drugs with digital health technologies could enhance the value proposition of ocular therapies." – Industry Report[23].
This analysis synthesizes market trends, competitive dynamics, and economic factors to outline a roadmap for stakeholders associated with NDC 71800-0031.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
